CD274 and endometrial carcinoma: Data indicated a novel association between dMMR and CAF PD-L1 expression, a possible potential additive biomarker of immune checkpoint inhibitor response in endometrial carcinoma, which remains to be confirmed in the future, to be tested and proven in larger cohorts, with longer follow-up data.